DK1253201T3 - Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor - Google Patents

Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor

Info

Publication number: DK1253201T3
Authority: DK; Denmark
Prior art keywords: cav; virus; induction; vaccines; infections
Prior art date: 1993-07-20

Application number

DK01205103T

Other languages

Danish (da)

English (en)

Inventor

Mathieu Hubertus Maria Noteborn

Guus Koch

Original Assignee

Leadd Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-20

Filing date

1994-07-19

Publication date

2008-11-17

1994-07-19 Application filed by Leadd Bv filed Critical Leadd Bv

2008-11-17 Application granted granted Critical

2008-11-17 Publication of DK1253201T3 publication Critical patent/DK1253201T3/da

Links

241000700605 Viruses Species 0.000 title abstract 4
229960005486 vaccine Drugs 0.000 title abstract 4
241000725585 Chicken anemia virus Species 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 5
102000004169 proteins and genes Human genes 0.000 abstract 5
208000015181 infectious disease Diseases 0.000 abstract 4
108020004414 DNA Proteins 0.000 abstract 2
210000004027 cell Anatomy 0.000 abstract 2
238000001514 detection method Methods 0.000 abstract 2
230000002163 immunogen Effects 0.000 abstract 2
230000006882 induction of apoptosis Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
230000003302 anti-idiotype Effects 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
238000003149 assay kit Methods 0.000 abstract 1
230000030833 cell death Effects 0.000 abstract 1
238000001415 gene therapy Methods 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
230000006698 induction Effects 0.000 abstract 1
230000002458 infectious effect Effects 0.000 abstract 1
230000003472 neutralizing effect Effects 0.000 abstract 1
230000001717 pathogenic effect Effects 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK01205103T 1993-07-20 1994-07-19 Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor DK1253201T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL9301272A NL9301272A (nl)	1993-07-20	1993-07-20	Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
PCT/NL1994/000168 WO1995003414A2 (en)	1993-07-20	1994-07-19	Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor

Publications (1)

Publication Number	Publication Date
DK1253201T3 true DK1253201T3 (da)	2008-11-17

Family

ID=19862681

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK01205103T DK1253201T3 (da)	1993-07-20	1994-07-19	Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor
DK94925638T DK0784685T3 (da)	1993-07-20	1994-07-19	Hønse-anæmi-virusmutanter og vacciner og anvendelser baseret på virusproteinerne VP1, VP2 og VP3 eller derfor kodende virussekvenser

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK94925638T DK0784685T3 (da)	1993-07-20	1994-07-19	Hønse-anæmi-virusmutanter og vacciner og anvendelser baseret på virusproteinerne VP1, VP2 og VP3 eller derfor kodende virussekvenser

Country Status (13)

Country	Link
US (1)	US5952002A (de)
EP (2)	EP0784685B1 (de)
JP (1)	JP3829290B2 (de)
AT (2)	ATE401406T1 (de)
AU (1)	AU703187B2 (de)
CA (1)	CA2167578C (de)
DE (2)	DE69435117D1 (de)
DK (2)	DK1253201T3 (de)
ES (2)	ES2311005T3 (de)
NL (1)	NL9301272A (de)
PT (2)	PT1253201E (de)
WO (1)	WO1995003414A2 (de)
ZA (1)	ZA945275B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5922600A (en) *	1990-09-12	1999-07-13	Leadd Bv	Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) *	1990-09-12	2008-09-25	Noteborn Mathieu H M	Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
EP0878546A1 (de) *	1997-04-15	1998-11-18	Leadd B.V.	Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
EP0872552A1 (de) *	1997-04-15	1998-10-21	Leadd B.V.	Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein und/oder Apoptin exprimiert
US5789567A (en) *	1994-07-06	1998-08-04	Cornell Research Foundation, Inc.	Chicken infectious anemia virus vaccine
GB9414888D0 (en) *	1994-07-23	1994-09-14	Univ Belfast	Method and composition
CA2221570A1 (en) *	1995-06-07	1996-12-19	Aesculaap B.V.	Neutralizing conformation epitopes of chicken anemia virus
DE69628431T2 (de) *	1995-06-07	2004-05-06	Leadd B.V.	Verwendungen von apoptin
EP0927757A1 (de) *	1997-12-03	1999-07-07	Leadd B.V.	Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
US7361730B1 (en) *	1999-03-15	2008-04-22	University Of Maryland	Surface localized colligin/Hsp47 in carcinoma cells
EP1199363A1 (de) *	2000-10-20	2002-04-24	Leadd B.V.	Phosphorylationsmodifikationen von Apoptin
AUPR567401A0 (en) *	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines
EP3868400A1 (de)	2005-12-29	2021-08-25	Boehringer Ingelheim Animal Health USA Inc.	Multivalente immunogene pcv2-zusammensetzungen und verfahren zur herstellung solcher zusammensetzungen
DK3766518T3 (da)	2005-12-29	2026-04-13	Boehringer Ingelheim Animal Health Usa Inc	Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
CN102311928B (zh) *	2011-08-25	2013-04-24	中国农业科学院哈尔滨兽医研究所	鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用
WO2017066772A1 (en)	2015-10-16	2017-04-20	Kansas State University Research Foundation	Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
MA43503B2 (fr) *	2016-04-26	2021-02-26	London School Of Hyghiene & Tropical Medicine	Arn viral simple brin isole (ssrna) derive du genome du virus de la peste equine (ahsv) pour la vaccination d'animaux contre le ahsv
CN113980146B (zh) *	2021-11-11	2022-09-27	扬州优邦生物药品有限公司	三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9002008A (nl) *	1990-09-12	1992-04-01	Stichting Centr Diergeneeskund	Recombinant dna en rna en daarvan afgeleide produkten.
ZA918426B (en) *	1990-10-31	1992-12-30	Akzo Nv	Chicken anemia virus vaccine and diagnostic
ZA927014B (en) *	1991-09-20	1993-03-19	Akzo Nv	Chicken anaemia agent vaccine.

1993
- 1993-07-20 NL NL9301272A patent/NL9301272A/nl not_active Application Discontinuation
1994
- 1994-07-19 DE DE69435117T patent/DE69435117D1/de not_active Expired - Fee Related
- 1994-07-19 PT PT01205103T patent/PT1253201E/pt unknown
- 1994-07-19 AT AT01205103T patent/ATE401406T1/de not_active IP Right Cessation
- 1994-07-19 ZA ZA945275A patent/ZA945275B/xx unknown
- 1994-07-19 PT PT94925638T patent/PT784685E/pt unknown
- 1994-07-19 AU AU75473/94A patent/AU703187B2/en not_active Ceased
- 1994-07-19 JP JP50507295A patent/JP3829290B2/ja not_active Expired - Lifetime
- 1994-07-19 DK DK01205103T patent/DK1253201T3/da active
- 1994-07-19 EP EP94925638A patent/EP0784685B1/de not_active Expired - Lifetime
- 1994-07-19 EP EP01205103A patent/EP1253201B1/de not_active Expired - Lifetime
- 1994-07-19 ES ES01205103T patent/ES2311005T3/es not_active Expired - Lifetime
- 1994-07-19 DE DE69432486T patent/DE69432486T2/de not_active Expired - Fee Related
- 1994-07-19 AT AT94925638T patent/ATE236980T1/de not_active IP Right Cessation
- 1994-07-19 WO PCT/NL1994/000168 patent/WO1995003414A2/en not_active Ceased
- 1994-07-19 DK DK94925638T patent/DK0784685T3/da active
- 1994-07-19 ES ES94925638T patent/ES2196032T3/es not_active Expired - Lifetime
- 1994-07-19 CA CA002167578A patent/CA2167578C/en not_active Expired - Fee Related
1997
- 1997-08-14 US US08/911,092 patent/US5952002A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ZA945275B (en)	1995-02-24
CA2167578A1 (en)	1995-02-02
DK0784685T3 (da)	2003-08-04
DE69435117D1 (de)	2008-08-28
PT1253201E (pt)	2008-10-27
ATE401406T1 (de)	2008-08-15
EP1253201A2 (de)	2002-10-30
AU7547394A (en)	1995-02-20
WO1995003414A2 (en)	1995-02-02
EP1253201A3 (de)	2003-01-08
WO1995003414A3 (en)	1995-03-02
ATE236980T1 (de)	2003-04-15
JPH09504941A (ja)	1997-05-20
NL9301272A (nl)	1995-02-16
DE69432486T2 (de)	2004-03-04
EP0784685B1 (de)	2003-04-09
ES2196032T3 (es)	2003-12-16
PT784685E (pt)	2003-08-29
CA2167578C (en)	2007-03-13
EP1253201B1 (de)	2008-07-16
US5952002A (en)	1999-09-14
JP3829290B2 (ja)	2006-10-04
ES2311005T3 (es)	2009-02-01
AU703187B2 (en)	1999-03-18
EP0784685A2 (de)	1997-07-23
DE69432486D1 (de)	2003-05-15

Publication	Publication Date	Title
DK1253201T3 (da)	2008-11-17	Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor
BR9712592A (pt)	1999-12-21	Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
DK84194A (da)	1994-07-12	Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
ATE97164T1 (de)	1993-11-15	Rekombinantes vaccinia-virus mva.
CY1115749T1 (el)	2017-01-25	Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
DE68919846D1 (de)	1995-01-19	Poxvirus-vektoren.
KR900700508A (ko)	1990-08-13	인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
RU94038050A (ru)	1996-05-10	Рекомбинантный вирус, вектор, вакцина, способ иммунизации, клетка-хозяин
ATE364083T1 (de)	2007-06-15	Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
FI861485A0 (fi)	1986-04-07	Producering av immunologiskt reaktiva virala proteiner.
DE3853139D1 (de)	1995-03-30	Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
KR890700030A (ko)	1989-03-02	인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
EP0236977A3 (de)	1989-05-03	Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
ATE122055T1 (de)	1995-05-15	Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
EP0257721A3 (en)	1988-06-08	Vaccine
DE69019092D1 (de)	1995-06-08	Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen).
Young	1988	Synthetic peptides as antigens: Ciba Foundation Symposium 119, John Wiley & Sons, 1986, 307 pp., ISBN 0471-998-389,£ 27.50
ES8801959A1 (es)	1988-03-01	Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida